OBJECTIVE

Manihot esculenta (Crantz) leaves have been used for the management of diabetes based on cited ethnopharmacological studies. However, scientific evidence to support its efficacy is lacking. The aim of the study was to assess the cytotoxicity of the aqueous leaf extract and fractions of Manihot esculenta and its potential hypoglycemic effect on male Swiss albino mice.

The cytotoxicity assay was necessary to screen which extract and fractions will be used for the in vivo hypoglycemic study.

Phytochemical screening identified the composition of the aqueous crude extract and its fractions. The phytochemical results showed the presence of alkaloids, anthraquinone glycosides, carbohydrates, phenolic glycosides, saponins, and flavonoids.

Cytotoxicity was screened using CytoTox 96® (Promega), a NonRadioactive Cytotoxicity Assay on liver cancer (HepG2) and normal kidney (HK-2) cell lines. Five samples were tagged as highly cytotoxic and were flagged for further assays. These samples were DCM fraction (100 ppm), n-Hexane fraction (1 and 10 ppm), Ethyl acetate fraction (1 ppm), and Aqueous fraction (100 ppm).

The hypoglycemic activity was examined in alloxan-induced diabetic mice using in vivo hypoglycemic study. The aqueous crude extract at dose levels of 200 mg/kg and 300 mg/kg body weight showed significant reduction in blood glucose levels compared to the diabetic control but not exceeding the results in the metformin treatment group. A p-value of 0.05 set a priori was used to consider whether the intervention had a statistically significant difference compared to the diabetic control.

The effectiveness of aqueous crude extract in reduction of blood glucose in mice may be attributed to the synergistic effects of phytochemicals present, especially the alkaloids which were retained in the extract but were undetectable in the fractionated samples. The results of this study also support the findings of existing ethnopharmacological studies on M. esculenta leaf extract as a hypoglycemic agent.

Objective: Manihot esculenta (Crantz) leaves have been used for the management of diabetes based on cited ethnopharmacological studies. However, scientific evidence to support its efficacy is lacking. The aim of the study was to assess the cytotoxicity of the aqueous leaf extract and fractions of Manihot esculenta and its potential hypoglycemic effect on male Swiss albino mice. Methods: The cytotoxicity assay was necessary to screen which extract and fractions will be used for the in vivo hypoglycemic study. : Phytochemical screening identified the composition of the aqueous crude extract and its fractions. The phytochemical results showed the presence of alkaloids, anthraquinone glycosides, carbohydrates, phenolic glycosides, saponins, and flavonoids. : Cytotoxicity was screened using CytoTox 96® (Promega), a NonRadioactive Cytotoxicity Assay on liver cancer (HepG2) and normal kidney (HK-2) cell lines. Five samples were tagged as highly cytotoxic and were flagged for further assays. These samples were DCM fraction (100 ppm), n-Hexane fraction (1 and 10 ppm), Ethyl acetate fraction (1 ppm), and Aqueous fraction (100 ppm). Results: The hypoglycemic activity was examined in alloxan-induced diabetic mice using in vivo hypoglycemic study. The aqueous crude extract at dose levels of 200 mg/kg and 300 mg/kg body weight showed significant reduction in blood glucose levels compared to the diabetic control but not exceeding the results in the metformin treatment group. A p-value of 0.05 set a priori was used to consider whether the intervention had a statistically significant difference compared to the diabetic control. Conclusion The effectiveness of aqueous crude extract in reduction of blood glucose in mice may be attributed to the synergistic effects of phytochemicals present, especially the alkaloids which were retained in the extract but were undetectable in the fractionated samples. The results of this study also support the findings of existing ethnopharmacological studies on M. esculenta leaf extract as a hypoglycemic agent.
alkaloids ; hypoglycemic agents ; ethnopharmacology

Objectives: A recent review on the status of Philippine ethnobotany showed the lack of ethnobotanical studies in the Visayas group of islands. The use of medicinal plants by the Eskaya, an Indigenous ethnic group in the province of Bohol in Visayas, Philippines, has not yet been documented. This study determines the ethnomedicinal knowledge of traditional healers in selected Eskaya communities in Bohol. Methods: Fifteen (15) Eskaya traditional healers were interviewed using a structured questionnaire, and the valuable medicinal plant species were identified through guided field walks. Informal group discussions with the community were also conducted. Moreover, the fidelity level, informant consensus factor (ICF), and use values (UV) were calculated. Results: Our results showed that the majority of the Eskaya healers belong to an older age group (38 – 71 years old). Eighty-five medicinal plants recorded belong to 44 plant families—with Family Lamiaceae having the highest number of species represented. The leaf is the most common plant part used for healing. Blumea balsamifera was an essential plant with a UV of 0.8. Cardiovascular diseases have the highest ICF values of 0.6, and the most common plants used for these diseases include Cymbopogon citratus, Zingiber officinale, and Luffa cylindrica. Conclusion Our study yielded a record of native and non-native medicinal plants used by the Eskaya healers. This initial listing is also their contribution to promoting medicinal plants that are accessible and abundant in their communities.
ethnobotany ; ethnopharmacology ; herbal medicine ; Philippines ; traditional medicine

The root of Scutellaria baicalensis Georgi, also called Huangqin, is frequently used in traditional Chinese medicine. In ancient China, S. baicalensis root was used to clear heat, protect the fetus, and avoid a miscarriage for thousands of years. In modern times, pregnancy-related diseases can seriously affect maternal and fetal health, but few systematic studies have explored the mechanisms and potential targets of S. baicalensis root in the treatment of pregnancy-related diseases. Flavonoids (baicalein, wogonin and oroxylin A) and flavonoid glycosides (baicalin and wogonoside) are the main chemical components in the root of S. baicalensis. This study presents the current understanding of the major chemical components in the root of S. baicalensis, focusing on their traditional uses, potential therapeutic effects and ethnopharmacological relevance to pregnancy-related disorders. The mechanisms, potential targets and experimental models of S. baicalensis root for ameliorating pregnancy-related diseases, such as recurrent spontaneous abortion, preeclampsia, preterm birth, fetal growth restriction and gestational diabetes mellitus, are highlighted.
Infant, Newborn ; Humans ; Pregnancy ; Female ; Scutellaria baicalensis ; Premature Birth/drug therapy* ; Flavonoids ; Plant Extracts/pharmacology* ; Medicine, Chinese Traditional ; Ethnopharmacology ; China

Aconitum heterophyllum (Patrees) is a critically endangered medicinal herb of the northwestern Himalayas and has enormous pharmacological potential. It is the only nonpoisonous member of the genus Aconitum, and has been used as a medicinal herb since ancient times. A. heterophyllum is an important ingredient in many traditional systems of medicine. Mostly, it is harvested for its roots, and its medicinal properties are due to the presence of diverse bioactive secondary metabolites, commonly known as aconites. Our understanding of the pharmacological properties of this intriguing genus is continuously growing due to its broad chemical diversity. The therapeutic uses identified by traditional medicinal practice are receiving extensive study. Multiple in vitro experimental investigations of A. heterophyllum have reported the analgesic, anti-inflammatory, antiarrhythmic, antiparasitic and anticancer properties, as well as its effects on the central nervous system. In this review, we highlight the classification, distribution, commerce, traditional uses, phytochemistry, pharmacology and conservation measures relevant to this species. Additionally, this review includes the biosynthetic pathways of A. heterophyllum's key constituents, which could be targeted to enhance the expression levels of desired metabolites via genetic interventions. Studying the genomics, transcriptomics, proteomics and metabolomic aspects of this species would be helpful in developing highly designed genotypes and chemotypes of this species to be used in commercial production.
Aconitum/genetics* ; Ethnopharmacology ; Plant Extracts/chemistry* ; Plant Roots/chemistry* ; Plants, Medicinal/chemistry*

Peperomia pellucida (L.) Kunth is a medicinal plant used to manage inflammatory illnesses such as conjunctivitis, and gastrointestinal and respiratory tract disorders in tropical and subtropical regions. However, little is known about its pharmacological mechanism of action against eye diseases. This review aims to critically discuss the phytochemistry, pharmacology and toxicology of P. pellucida as well as its roles in the treatment of cataract, glaucoma and diabetic retinopathy. Recent developments in the uses of P. pellucida for healthcare and nutraceutical products by the pharmaceutical industry are also covered in this review. For this review, a literature search was performed with PubMed, ScienceDirect, SciFinder Scholar and Scopus databases, using relevant keywords. Among the various phytochemicals identified from P. pellucida, β-caryophyllene, carotol, dillapiole, ellagic acid, pellucidin A, phytol and vitexin exhibit strong pharmacological activities within the mitogen-activated protein kinase and nuclear factor-κB signalling pathways in inflammatory eye diseases. The antihypertensive, anti-inflammatory, antioxidant, antihyperglycemic and anti-angiogenic activities displayed by P. pellucida extracts in many in vitro, in vivo and clinical studies suggest its potential role in the management of inflammatory eye diseases. P. pellucida extract was non-toxic against normal cell lines but displayed mild toxicity in animal models. The growing public interest in P. pellucida has inspired the nutraceutical and pharmaceutical industries to process the plant into health products. Although the potential pharmacological mechanisms against eye diseases have been summarized, further studies of the interactions among constituent phytochemicals from P. pellucida within various signalling pathways shall support the use of the plant as an alternative therapeutic source.
Animals ; Ethnopharmacology ; Eye Diseases/drug therapy* ; Peperomia ; Phytochemicals/therapeutic use* ; Phytotherapy ; Plant Extracts/therapeutic use* ; Plants, Medicinal

Rhizoma phragmitis is a common Chinese herbal medicine whose effects are defined as 'clearing heat and fire, promoting fluid production to quench thirst, eliminating irritability, stopping vomiting, and disinhibiting urine'. During the Novel Coronavirus epidemic in 2020, the Weijing Decoction and Wuye Lugen Decoction, with Rhizoma phragmitis as the main herbal component, were included in The Pneumonia Treatment Protocol for Novel Coronavirus Infection (Trial Version 5) due to remarkable antiviral effects. Modern pharmacological studies have shown that Rhizoma phragmitis has antiviral, antioxidative, anti-inflammatory, analgesic, and hypoglycemic functions, lowers blood lipids and protects the liver and kidney. This review aims to provide a systematic summary of the botany, traditional applications, phytochemistry, pharmacology and toxicology of Rhizoma phragmitis.
Humans ; Plant Extracts/pharmacology* ; Rhizome ; Drugs, Chinese Herbal/therapeutic use* ; Antioxidants/therapeutic use* ; Antiviral Agents/therapeutic use* ; Medicine, Chinese Traditional ; Phytochemicals/therapeutic use* ; Ethnopharmacology ; COVID-19 Drug Treatment

Background: Despite the mounting studies on the practical use of species of the pantropical family Melastomataceae, especially their medicinal utility, no attempt at compiling the diverse findings has been made to date. Moreover, most reviews of medicinal flora tend to focus more on the biomedical properties of the plants than their equally meaningful evolutionary and ethnobiological aspects. Objectives: This review aimed to describe and synthesize the current knowledge from and trends in medicinal studies of locally relevant members of the Melastomataceae. Specifically, it sought to gather, select, assess, and analyze digitally available field studies about the anti-infective potential of the genera of the Melastomataceae that occur in the Philippines using a combined evolutionary and ethnobiological lens. Methodology: Web-based search was conducted in EBSCO, Google Scholar, PubMed, ScienceDirect, Scopus, and local databases of medicinal ethnobotany for full and original research papers in Filipino or English. Studies were screened and assessed independently based on taxonomic reliability and ethnobiological methodology. Data were analyzed qualitatively using an integrated evolutionary and ethnobiological framework. Results: Thirty-four ethnobiological studies comprising journal articles and theses that surveyed 41 localities and cultural groups from 12 countries were reviewed. Three Philippine native melastome species are used in treating potentially infectious conditions: Dissochaeta divaricata, Melastoma malabathricum, and M. sanguineum. Other genera native to the Philippines with congeneric species used for anti-infective purposes elsewhere are Medinilla, Memecylon, Osbeckia, and Sonerila. Indications with the most cross-regional consensus include cuts, wounds, and skin infections, diarrhea and dysentery, and buccal, respiratory, and urogenital infections. Conclusion This review revealed that Philippine native melastome genera and species are available for infectious disease mitigation and exhibit high use convergence across geographically and culturally divergent communities but remain untapped. Documenting medicinal flora in an area or community based on their evolutionary relationships and ethnomedicinal usage is significant not only in bioprospecting but more importantly, in preserving indigenous knowledge and natural patrimony, especially amid collapsing socioecological systems and emerging diseases.
Ethnobotany ; Medicine, Traditional ; Ethnopharmacology ; Herbal Medicine ; Medicine, Traditional

Through summarizing the applications and funding for research related to ethnomedicine and ethnopharmacology in the department of Health Sciences of the National Natural Science Foundation of China( NSFC) from 1986 to 2018,and analyzing the categories,numbers,funds and research contents of all funded projects including Mongolian,Uygur,Tibetan,Zhuang,Miao,the study is aimed to provide certain reference for the declaration of ethnic medicine project. The results showed that the national medicine project application numbers and the amount of funding growth after 2011 have increased significantly,but the overall level of research remained to be further promoted,and the lack of suitable for the study of ethnic medicine features and ways,has yet to mainland medical universities and research institutions to give more attention and jointly promote the development of basic research in the field of ethnic medicine.
China ; Ethnopharmacology ; Financial Management ; Foundations ; Medicine, Traditional

Ethnomedicine is the precious wealth left by ethnic minorities in their struggle against diseases. It is similar to traditional Chinese medicine in a narrow sense and has the characteristics of multi-component,multi-target and multi-channel synergy. Under the guidance of the theory of ethnomedicine,the combination of ethnomedicine and network pharmacology will help to understand the essence of the prevention and treatment of ethnomedicines in a dynamic and holistic manner. This paper reviews the research progress of network pharmacology applied in ethnomedicine,analyses the problems and challenges existing in the application of network pharmacology in ethnomedicine research at present,such as inaccurate data and information,lack of network analysis platform for effective analysis of dose-effect relationship of chemical constituents and weak basic research of ethnomedicine,and puts forward corresponding prospects.
Ethnopharmacology ; Medicine, Chinese Traditional ; Medicine, Traditional